Frontage Holdings Corp
HKEX:1521

Watchlist Manager
Frontage Holdings Corp Logo
Frontage Holdings Corp
HKEX:1521
Watchlist
Price: 1.04 HKD -1.89%
Market Cap: HK$2.1B

Net Margin

0.2%
Current
Declining
by 0.3%
vs 3-y average of 0.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0.2%
=
Net Income
$3.8m
/
Revenue
$253m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0.2%
=
Net Income
HK$3.8m
/
Revenue
$253m

Peer Comparison

Country Company Market Cap Net
Margin
US
Frontage Holdings Corp
HKEX:1521
2.1B HKD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
220B USD
Loading...
US
Danaher Corp
NYSE:DHR
157.4B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
39.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
267.6B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
US
Waters Corp
NYSE:WAT
22.4B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
42st
Based on 15 072 companies
42st percentile
0.2%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Frontage Holdings Corp
Glance View

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.

Intrinsic Value
1.13 HKD
Undervaluation 8%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
0.2%
=
Net Income
$3.8m
/
Revenue
$253m
What is Frontage Holdings Corp's current Net Margin?

The current Net Margin for Frontage Holdings Corp is 0.2%, which is below its 3-year median of 0.5%.

How has Net Margin changed over time?

Over the last 3 years, Frontage Holdings Corp’s Net Margin has decreased from 1.3% to 0.2%. During this period, it reached a low of 0% on Dec 31, 2024 and a high of 1.3% on Dec 31, 2022.

Back to Top